Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2014

01-09-2014 | Original Article

Pancreatic Hyperenzymemia Is Associated with Bacterial Culture Positivity, More Severe and Right-Sided Colitis

Authors: Bum Su Choung, Seong Hun Kim, Seung Young Seo, In Hee Kim, Sang Wook Kim, Seung-Ok Lee, Soo Teik Lee

Published in: Digestive Diseases and Sciences | Issue 9/2014

Login to get access

Abstract

Background/Aim

Several studies reported pancreatic hyperenzymemia (PHE) related to acute colitis. However, there is no consensus on its clinical significance. This study was addressed to find the clinical significance of PHE in acute colitis.

Methods

Pancreatic hyperenzymemia was defined as abnormal increase in serum concentrations of the pancreatic enzymes by three times of normal upper range without definite pancreatic symptoms and evidence of pancreatitis at abdominal CT imaging of pancreatic disease. And clinical and laboratory and biologic parameters of PHE group and normal pancreatic enzymemia (NPE) group were compared.

Results

A total of 1,069 patients admitted to hospitals due to acute colitis were analyzed. Of these patients, 2.99 % (32/1,069) showed PHE. PHE group showed more severe symptoms and had longer hospital stays than the NPE group (12.15 vs. 4.59 days; P < 0.001). Multivariable analysis showed that right-sided colitis (OR 2.846; 95 % CI 1.122–7.224; P = 0.028) and culture positivity (OR 3.346; 95 % CI 1.119–10.008; P = 0.031) are associated with PHE during acute colitis. Also, PHE group was more common when a microorganism could be identified in the cultures (28.1 vs. 7.0 %; P = 0.003), especially blood culture. Among patients with positive cultures, Salmonella spp. had a positive correlation with the right-sided colitis and PHE (amylase P = 0.002; lipase P = 0.029), Salmonella serovar typhimurium (group B) was especially related to increased serum lipase but not to increased serum amylase (lipase; P = 0.041: amylase; P = 0.485).

Conclusion

Pancreatic hyperenzymemia is associated with right-sided colitis, bacterial culture positivity, and severe acute colitis.
Literature
1.
go back to reference Madej B, Maciejewski R, Anasiewicz A, Radzikowska E. The effect of intraperitoneally administered necrolytic enzymes on the course of experimental acute pancreatitis. Wiad Lek. 1997;50:101–107.PubMed Madej B, Maciejewski R, Anasiewicz A, Radzikowska E. The effect of intraperitoneally administered necrolytic enzymes on the course of experimental acute pancreatitis. Wiad Lek. 1997;50:101–107.PubMed
2.
go back to reference Cappell MS. Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. Med Clin North Am. 2008; 92:889–923, ix–x. Cappell MS. Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. Med Clin North Am. 2008; 92:889–923, ix–x.
3.
go back to reference Ben-Horin S, Farfel Z, Mouallem M. Gastroenteritis-associated hyperamylasemia: prevalence and clinical significance. Arch Intern Med. 2002;162:689–692.PubMedCrossRef Ben-Horin S, Farfel Z, Mouallem M. Gastroenteritis-associated hyperamylasemia: prevalence and clinical significance. Arch Intern Med. 2002;162:689–692.PubMedCrossRef
4.
go back to reference Tositti G, Fabris P, Barnes E, et al. Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance. BMC Infect Dis. 2001;1:18.PubMedCentralPubMedCrossRef Tositti G, Fabris P, Barnes E, et al. Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance. BMC Infect Dis. 2001;1:18.PubMedCentralPubMedCrossRef
5.
go back to reference Reimund JM, Muller CD, Finck G, Escalin G, Duclos B, Baumann R. Factors contributing to infectious diarrhea-associated pancreatic enzyme alterations. Gastroenterol Clin Biol. 2005;29:247–253.PubMedCrossRef Reimund JM, Muller CD, Finck G, Escalin G, Duclos B, Baumann R. Factors contributing to infectious diarrhea-associated pancreatic enzyme alterations. Gastroenterol Clin Biol. 2005;29:247–253.PubMedCrossRef
6.
go back to reference Apple F, Benson P, Preese L, Eastep S, Bilodeau L, Heiler G. Lipase and pancreatic amylase activities in tissues and in patients with hyperamylasemia. Am J Clin Pathol. 1991;96:610–614.PubMed Apple F, Benson P, Preese L, Eastep S, Bilodeau L, Heiler G. Lipase and pancreatic amylase activities in tissues and in patients with hyperamylasemia. Am J Clin Pathol. 1991;96:610–614.PubMed
7.
go back to reference Smith RC, Southwell-Keely J, Chesher D. Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? Anz J Surg. 2005;75:399–404.PubMedCrossRef Smith RC, Southwell-Keely J, Chesher D. Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? Anz J Surg. 2005;75:399–404.PubMedCrossRef
8.
go back to reference Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal-pain versus acute-pancreatitis. Am J Gastroenterol. 1993;88:2051–2055.PubMed Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal-pain versus acute-pancreatitis. Am J Gastroenterol. 1993;88:2051–2055.PubMed
9.
go back to reference Pacheco RC, Oliveira LC. Lipase/amylase ratio in biliary acute pancreatitis and alcoholic acute/acutized chronic pancreatitis. Arq Gastroenterol. 2007;44:35–38.PubMedCrossRef Pacheco RC, Oliveira LC. Lipase/amylase ratio in biliary acute pancreatitis and alcoholic acute/acutized chronic pancreatitis. Arq Gastroenterol. 2007;44:35–38.PubMedCrossRef
10.
go back to reference Pezzilli R, Fantini L. Lipase/amylase ratio and liver function tests for the etiological assessment of acute pancreatitis: facts and fiction. Recenti Prog Med. 2006;97:477–480.PubMed Pezzilli R, Fantini L. Lipase/amylase ratio and liver function tests for the etiological assessment of acute pancreatitis: facts and fiction. Recenti Prog Med. 2006;97:477–480.PubMed
11.
go back to reference Nylund K, Hausken T, Odegaard S, Eide GE, Gilja OH. Gastrointestinal wall thickness measured with transabdominal ultrasonography and its relationship to demographic factors in healthy subjects. Ultraschall Med. 2012;33:E225–E232.PubMedCrossRef Nylund K, Hausken T, Odegaard S, Eide GE, Gilja OH. Gastrointestinal wall thickness measured with transabdominal ultrasonography and its relationship to demographic factors in healthy subjects. Ultraschall Med. 2012;33:E225–E232.PubMedCrossRef
12.
go back to reference Teefey SA, Roarke MC, Brink JA, et al. Bowel wall thickening: differentiation of inflammation from ischemia with color Doppler and duplex US. Radiology. 1996;198:547–551.PubMedCrossRef Teefey SA, Roarke MC, Brink JA, et al. Bowel wall thickening: differentiation of inflammation from ischemia with color Doppler and duplex US. Radiology. 1996;198:547–551.PubMedCrossRef
13.
go back to reference Clark L, Perrett CA, Malt L, et al. Differences in Salmonella enterica serovar typhimurium strain invasiveness are associated with heterogeneity in SPI-1 gene expression. Microbiology. 2011;157:2072–2083.PubMedCentralPubMedCrossRef Clark L, Perrett CA, Malt L, et al. Differences in Salmonella enterica serovar typhimurium strain invasiveness are associated with heterogeneity in SPI-1 gene expression. Microbiology. 2011;157:2072–2083.PubMedCentralPubMedCrossRef
14.
go back to reference Kiriyama S, Gabata T, Takada T, et al. New diagnostic criteria of acute pancreatitis. J Hepatobiliary Pancreat Sci. 2010;17:24–36.PubMedCrossRef Kiriyama S, Gabata T, Takada T, et al. New diagnostic criteria of acute pancreatitis. J Hepatobiliary Pancreat Sci. 2010;17:24–36.PubMedCrossRef
15.
go back to reference Demden MC, Wong L, Harris OD. Serum amylase, isoamylase and lipase in acute alcoholism. Aust N Z J Med. 1984;14:819–821.CrossRef Demden MC, Wong L, Harris OD. Serum amylase, isoamylase and lipase in acute alcoholism. Aust N Z J Med. 1984;14:819–821.CrossRef
16.
go back to reference Clave P, Guillaumes S, Blanco I, et al. Amylase, lipase, pancreatic isoamylase, and phospholipase-A in diagnosis of acute-pancreatitis. Clin Chem. 1995;41:1129–1134.PubMed Clave P, Guillaumes S, Blanco I, et al. Amylase, lipase, pancreatic isoamylase, and phospholipase-A in diagnosis of acute-pancreatitis. Clin Chem. 1995;41:1129–1134.PubMed
17.
go back to reference Renner F, Nimeth C, Demmelbauer N. High frequency of concomitant pancreatitis in Salmonella enteritis. Lancet. 1991;337:1611.PubMedCrossRef Renner F, Nimeth C, Demmelbauer N. High frequency of concomitant pancreatitis in Salmonella enteritis. Lancet. 1991;337:1611.PubMedCrossRef
18.
go back to reference Pezzilli R, Morselli-Labate AM, Barakat B, et al. Pancreatic involvement in Salmonella infection. JOP. 2003;4:200–206.PubMed Pezzilli R, Morselli-Labate AM, Barakat B, et al. Pancreatic involvement in Salmonella infection. JOP. 2003;4:200–206.PubMed
19.
go back to reference Mehta A, Singh S, Ganguly NK. Impairment of intestinal mucosal antioxidant defense system during Salmonella typhimurium infection. Dig Dis Sci. 1998;43:646–651.PubMedCrossRef Mehta A, Singh S, Ganguly NK. Impairment of intestinal mucosal antioxidant defense system during Salmonella typhimurium infection. Dig Dis Sci. 1998;43:646–651.PubMedCrossRef
20.
go back to reference Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003;52:439–451.PubMedCentralPubMedCrossRef Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003;52:439–451.PubMedCentralPubMedCrossRef
21.
go back to reference Vasilescu C, Herlea V, Buttenschoen K, Beger HG. Endotoxin translocation in two models of experimental acute pancreatitis. J Cell Mol Med. 2003;7:417–424.PubMedCrossRef Vasilescu C, Herlea V, Buttenschoen K, Beger HG. Endotoxin translocation in two models of experimental acute pancreatitis. J Cell Mol Med. 2003;7:417–424.PubMedCrossRef
22.
go back to reference Gupta JD, Reed CE. The role of serum lipase in the degradation of Salmonella enteritidis endotoxin. J Immunol. 1968;101:308–316.PubMed Gupta JD, Reed CE. The role of serum lipase in the degradation of Salmonella enteritidis endotoxin. J Immunol. 1968;101:308–316.PubMed
23.
go back to reference Gnadinger MP, Eigenmann F, Bekier A, Galeazzi RL. Pseudopancreatitis in entero-invasive salmonellosis. Schweiz Med Wochenschr. 1993;123:1482–1486.PubMed Gnadinger MP, Eigenmann F, Bekier A, Galeazzi RL. Pseudopancreatitis in entero-invasive salmonellosis. Schweiz Med Wochenschr. 1993;123:1482–1486.PubMed
25.
go back to reference Lee WC, Lee MJ, Kim JS, Park SY. Foodborne illness outbreaks in Korea and Japan studied retrospectively. J Food Prot. 2001;64:899–902.PubMed Lee WC, Lee MJ, Kim JS, Park SY. Foodborne illness outbreaks in Korea and Japan studied retrospectively. J Food Prot. 2001;64:899–902.PubMed
26.
go back to reference Cho SH, Shin HH, Choi YH, Park MS, Lee BK. Enteric bacteria isolated from acute diarrheal patients in the Republic of Korea between the year 2004 and 2006. J Microbiol. 2008;46:325–330.PubMedCrossRef Cho SH, Shin HH, Choi YH, Park MS, Lee BK. Enteric bacteria isolated from acute diarrheal patients in the Republic of Korea between the year 2004 and 2006. J Microbiol. 2008;46:325–330.PubMedCrossRef
Metadata
Title
Pancreatic Hyperenzymemia Is Associated with Bacterial Culture Positivity, More Severe and Right-Sided Colitis
Authors
Bum Su Choung
Seong Hun Kim
Seung Young Seo
In Hee Kim
Sang Wook Kim
Seung-Ok Lee
Soo Teik Lee
Publication date
01-09-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3146-y

Other articles of this Issue 9/2014

Digestive Diseases and Sciences 9/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine